Loading
AC
Abbisko Cayman Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by JI JING, was filed 09 Jun 2026.
Insider Decl.
78
Thresholds
n/a
Buy Volume
€1M
30 ops. · all time
Sell Volume
€373,485
21 ops. · all time
Who traded when
BuySaleXu Yao-Chang7 buys3 sales
Yu Hongping2 buys6 sales
Ji Jing2 buys4 sales
Chen Zhui1 buy2 sales
Since the insiders bought
- +2.6%Entry HK$8.72 · Close at T+90 HK$8.94
- -40.8%Entry HK$11.88 · Close 22 Oct 2026 HK$7.03
- +121.9%Entry HK$2.79 · Close at T+365 HK$6.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 16,476 of 26,286 companies
43.5
score / 100
Value31
Quality56
FCF yld1.4%
Earn yld1.1%
EV/EBITDA38.2x
ROE-21%
Gross mgn100%
Net mgn9.0%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$7.15
Analyst consensus
6 analysts1.13/5
HK$17.81Target HK$21.85(+206%)HK$26.70
Income statement
RevenueHK$612.1M
Gross profitHK$612.1M100% margin
EBITDAHK$142.1M23% margin
Net incomeHK$55.2M9.0% margin
Valuation
PER (trailing)90.1x
PER (forward)-31.3x
P/Book2.0x
Beta1.17
Balance sheet & cash
Market capHK$5.1B
Total debtHK$303.5M
Free Cash FlowHK$73.8M
Debt / Equity21%
Profitability & ownership
ROE-21.2%
ROA-12.6%
% insiders16.2%
% institutions37.6%
Last declaration on 2 October 2026
Declarations78 total
113,797 sharesShareXHKGHKEX:DA20261002E00056
61,152 sharesShareXHKGHKEX:DA20261002E00063
167,394 sharesShareXHKGHKEX:DA20261002E00060
2,000,000 sharesShareXHKGHKEX:DA20260609E00050
Canonical exit: 2 Sept 2026 (T+90)
60,000 shares@ HK$13.06870.011% mcap42.8% of flowShareXHKGHKEX:DA20260409E00481
22,000 shares@ HK$12.950.0040% mcap15.6% of flowShareXHKGHKEX:DA20260409E00480
60,000 shares@ HK$12.75180.011% mcap41.6% of flowShareXHKGHKEX:DA20260409E00418
90,000 shares@ HK$12.71440.016% mcap73.6% of flowShareXHKGHKEX:DA20260409E00420
6,000 shares@ HK$13.25830.0011% mcap5.1% of flowShareXHKGHKEX:DA20260409E00464
25,000 shares@ HK$13.1820.0046% mcap21.3% of flowShareXHKGHKEX:DA20260409E00463
45,000 shares@ HK$11.26100.0% of flowShareXHKGHKEX:DA20260305E00044
Canonical exit: 1 Jun 2026 (T+90)
1,087,136 sharesShareXHKGHKEX:DA20250930E00435
Canonical exit: 28 Dec 2025 (T+90)
1,689,988 sharesShareXHKGHKEX:DA20250930E00436
Canonical exit: 28 Dec 2025 (T+90)
1,087,136 sharesShareXHKGHKEX:DA20250930E00433
Canonical exit: 28 Dec 2025 (T+90)
17,000 shares@ HK$10.406.3% of flowShareXHKGHKEX:DA20250613E00013
Canonical exit: 10 Sept 2025 (T+90)
30,000 shares@ HK$7.9578.8% of flowShareXHKGHKEX:DA20250507E00018
Canonical exit: 4 Aug 2025 (T+90)
40,000 shares@ HK$7.5711.6% of flowShareXHKGHKEX:DA20250313E00319
Canonical exit: 11 Jun 2025 (T+90)
45,000 shares@ HK$6.4811.5% of flowShareXHKGHKEX:DA20250305E00244
Canonical exit: 2 Jun 2025 (T+90)
97,093,374 sharesShareXHKGHKEX:DA20250304E00132
34,397,788 sharesShareXHKGHKEX:DA20250304E00120
97,110,374 sharesShareXHKGHKEX:DA20250304E00126
3,289,719 sharesShareXHKGHKEX:DA20241227E00299
2,040,000 sharesShareXHKGHKEX:DA20241227E00262
Canonical exit: 20 Mar 2025 (T+90)
1,237,500 sharesShareXHKGHKEX:DA20241227E00321
1,544,656 sharesShareXHKGHKEX:DA20241227E00307
25 of 78 declarations
About Abbisko Cayman Ltd. - B
Only five directors make up the record of Abbisko Cayman Ltd. - B, and they share 78 filings. Xu Yao-Chang (Director) filed 23, including 13 purchases and 5 sales; Yu Hongping 21, with 8 purchases and 8 sales; Chen Zhui 16; Yeh Richard 12, of which 11 purchases and no sale; Ji Jing 6, with 2 purchases and 4 sales.
The three largest purchases are Yeh Richard's in November 2021: EUR 122,571 on November 15, 2021, EUR 121,468 on November 16, 2021 and EUR 122,377 on November 17, 2021. In total, 34 purchases with an amount out of 41 weigh EUR 1,470,098, with a median of EUR 35,435. On the sale side, 6 of 21 carry an amount, EUR 373,485 in all, including EUR 125,952 for Yu Hongping on April 1, 2026 and EUR 86,682 for Ji Jing on April 2, 2026.
Read moreShow less
A health care and pharma company listed on the Hong Kong stock exchange, valued at HKD 5.6 billion, of which 16.2% is held by filers. On September 29, 2025, three directors bought on the same day. The pace peaks at 21 filings in 2024. Over the latest twelve months: 11 filings, made up of 2 purchases and 9 sales. Median publication delay: 4 days. For 35 purchases, the recorded 90-day return has a median of minus 9.6% and 49% positive cases, recorded past results, not a forecast.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
